BIO-B12 1000.0 MCG
VITAMIN B12 (CYANOCOBALAMIN) : 1000.0 MCG ZINC (ZINC CITRATE) : 15.0 MG FOLIC ACID : 0.8 MG · DIN 02231905 · THORNE RESEARCH INC.
Health Canada status: CANCELLED POST MARKET
What is BIO-B12?
BIO-B12 1000.0 MCG contains VITAMIN B12 (CYANOCOBALAMIN) : 1000.0 MCG ZINC (ZINC CITRATE) : 15.0 MG FOLIC ACID : 0.8 MG. It is listed in the Health Canada Drug Product Database under DIN 02231905, held by THORNE RESEARCH INC., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Aug-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02231905 |
|---|---|
| Brand name | BIO-B12 |
| Generic / active ingredient | VITAMIN B12 (CYANOCOBALAMIN) : 1000.0 MCG ZINC (ZINC CITRATE) : 15.0 MG FOLIC ACID : 0.8 MG |
| Manufacturer | THORNE RESEARCH INC. |
| Strength | 1000.0 MCG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | B03BA51 CYANOCOBALAMIN, COMBINATIONS |
| AHFS class | 88:28.01* ; See footnote |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Aug-2006 |
| Original market date | 1997-09-09 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B03BA51 CYANOCOBALAMIN, COMBINATIONS. 0 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| B6, B12 & FOLIC ACID | 0.4 MG | CAPSULE | NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | CANCELLED POST MARKET | DIN 02244345 |
| COOL B | 300 MCG | CAPSULE | SISU INC. | CANCELLED POST MARKET | DIN 02244400 |
| FORMULA CH. LES. | 0.40 MG | TABLET | ABUNDANCE NATURALLY LTD | CANCELLED POST MARKET | DIN 02245343 |
| LIVER DESICCATED + B12 TAB | 486 MG | TABLET | LE NATURISTE J.M.B. INC. | CANCELLED POST MARKET | DIN 00385158 |
| LIVER TAB W VITAMIN B12 DESICCATED | 1 MCG | TABLET | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | DIN 00215821 |
| SUPER B12 + FOLIC ACID | 1000 MCG | TABLET | SEROYAL INTERNATIONAL INC. | CANCELLED POST MARKET | DIN 02236892 |
| VITA-FOLIC-B CAPS | 500 MCG | CAPSULE | LES LABORATOIRES VACHON INC. | CANCELLED POST MARKET | DIN 00757810 |
| VITAMIN B12 PLUS TABLETS W FOLIC ACID | .4 MG | TABLET | NU-LIFE NUTRITION LTD. | CANCELLED POST MARKET | DIN 00663042 |
| VITAMIN B12-FOLIC ACID | .4 MG | TABLET | SEROYAL INTERNATIONAL INC. | CANCELLED POST MARKET | DIN 00700835 |
| VITAMIN B6 & B12 WITH FOLIC ACID | 0.4 MG | CAPSULE | WN PHARMACEUTICALS LTD. | CANCELLED POST MARKET | DIN 02245307 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.